CEACAM5 and neoplasm: Recent examples include OTL38, which binds to folate receptors overexpressed in certain cancers, and IRDye 800CW, which can be conjugated to tumour-specific antibodies [16], and SGM-101, which is a fluorochrome-labelled anti-carcinoembryonic antigen (CEA) monoclonal antibody.